Le Lézard
Classified in: Sports and recreation, Covid-19 virus
Subject: MRR

Climbing gym market size to increase by USD 4,185.74 million from 2021 to 2026: North America will account for 36% of market growth - Technavio


NEW YORK, March 22, 2023 /PRNewswire/ -- The climbing gym market report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 12.5% and register an incremental growth of USD 4,185.74 million during the forecast period. The market growth will be driven by factors such as the increasing popularity of outdoor sports, the growing awareness among people about fitness and healthy lifestyles, and the rise in the construction of climbing walls. However, the risks of accidents and injuries associated with climbing activities will challenge the market growth. Climbing activities include top-roping, speed climbing, bouldering, and lead climbing, among others. Rock climbing is considered dangerous due to the risk of injuries. Bouldering accounts for a major percentage of all climbing-related accidents and injuries. Some of the injuries caused by climbing activities include knee sprains, neck injuries, ankle ligament sprains, fractures, groin strains, contusions, and shoulder dislocations. These factors will hinder the global market during the forecast period. Drivers and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

Regional analysis

Based on region, the global climbing gym market is segmented into North America, APAC, Europe, South America, and the Middle East and Africa. North America is estimated to account for 36% of the growth of the global market during the forecast period. The US is the largest market for climbing gyms in the region owing to the presence of a well-developed sports industry and the high incidence of obesity and diabetes. Therefore, many people in the country participate in sporting activities, such as climbing, to remain healthy. The participation rates in indoor and outdoor climbing have been increasing over the last few years. The emergence of interactive climbing walls and the rise in the number of tourists are also increasing participation rates. North America is a popular destination for many adventure sports, including climbing. Such sports offer various benefits to participants, such as reducing stress, socializing opportunities, and improvement of general well-being. These factors will lead to the launch of more sports clubs and thereby boost the regional market's growth during the forecast period.

Market segmentation

The market is segmented into application (top-rope climbing, lead climbing, and bouldering) and type (indoor and outdoor). The top-rope climbing segment will account for a significant share of the market growth during the forecast period. Top-rope climbing is also known as top roping. It is a form of rock climbing wherein the climber is securely fastened to a rope by a belayer at the bottom and an anchor system at the top. The popularity of top-rope climbing has increased over the years. It is preferred by a large number of people as a workout, sport, or recreational activity. Top-rope climbing can be done indoors and outdoors. This segment is expected to grow during the forecast period, as top-rope climbing will become more accessible to people in climbing gyms. Modern climbing equipment ensures a high degree of climbing safety. Factors are driving the segment's growth.

Company profiles

The climbing gym market report includes information on the key products and recent developments of leading vendors, including:

Competitive analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, among others. Request a sample

What are the key data covered in this climbing gym market report?

What's New?

Related Reports:

The outdoor gym equipment market size is expected to increase by USD 687.37 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.13%. The increasing awareness of diabetes and obesity is notably driving the outdoor gym equipment market growth, although factors such as lack of expert training personnel may impede the market growth.

The connected gym equipment market is estimated to grow at a CAGR of 28.15% between 2022 and 2027. The size of the market is forecast to increase by USD 16,348.77 million. Increasing smartphone penetration and growing demand for connected gym services are notably driving the market growth, although factors such as lack of awareness of products and technology may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

Climbing Gym Market Scope

Report Coverage

Details

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12.5%

Market growth 2023-2027

USD 4,185.74 million

Market structure

Fragmented

YoY growth 2022-2023(%)

12.0

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 36%

Key countries

US, China, Japan, Germany, and UK

Competitive landscape

Leading vendors, market positioning of vendors, competitive strategies, and industry risks

Key companies profiled

Boulderklub Kreuzberg GmbH, Brooklyn Boulders LLC, CityROCK, Climb So iLL, Glasgow Climbing Centre, Go Nature H.K. Ltd., High Point, Latitude Climbing LLC, Momentum Indoor Climbing, Movement, Sender One Climbing LLC, Sputnik Climbing SL, The Castle Climbing Centre, The Cliffs, The Gravity Vault Indoor Rock Gyms, Uprising Climbing Walls Ltd., Vertical Endeavors, Vertical World Inc., Climbing Centre Group Ltd., and Sharma Climbing SL

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio consumer discretionary market reports

Table of contents:

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Application

7 Market Segmentation by Type

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 12:00
Precigen Announces Positive Phase 1 Data for Off-the-Shelf PRGN-2009 AdenoVersetm Immunotherapy Alone and in Combination with an Investigational Checkpoint Inhibitor in Patients with Recurrent/Metastatic HPV-associated Cancers
?  PRGN-2009 combined with an investigational checkpoint inhibitor resulted in a 30% ORR in patients with heavily pre-treated HPV-associated cancers that were naïve or resistant to checkpoint blockade with prolonged duration of responses?? ? ...

at 11:00
BEYOND MEAT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Beyond Meat To Contact Him Directly To Discuss Their Options
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beyond Meat, Inc. ("Beyond Meat" or the "Company") and reminds investors of the July 10, 2023 deadline to seek the role of lead plaintiff in a...

at 11:00
CUTERA DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Cutera To Contact Him Directly To Discuss Their Options
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Cutera, Inc. ("Cutera" or the "Company") and reminds investors of the July 24, 2023 deadline to seek the role of lead plaintiff in a federal...

at 09:05
Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Clinical Activity and Generally Well Tolerated Safety Profile
Cyteir Therapeutics, Inc. ("Cyteir") , a clinical stage oncology company, today presented results from a Phase 1 study with CYT-0851 in combination with capecitabine or gemcitabine in a poster titled "Phase 1 Results of CYT-0851, a Monocarboxylate...

at 09:05
Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery Reduced the Risk of Event-Free Survival Events by 42% Versus Pre-Operative Chemotherapy in Resectable Stage II, IIIA or IIIB NSCLC
Merck , known as MSD outside of the United States and Canada, today announced positive results from the pivotal Phase 3 KEYNOTE-671 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, as a perioperative treatment regimen, which includes treatment...

at 09:00
Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023
Elevation Oncology, Inc. , an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range...

More news about Covid-19 virus...


News published on and distributed by: